SEMUF yields 4.35% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, SEMUF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEMUF + JNJ for your $10,000?
Siem Industries S.A., through its subsidiaries, operates in the oil and gas services industry and renewable energy sector worldwide. It operates through Offshore Support Vessels, Reefer Vessels and Car Carriers, Potash Production, Roll-on/Rolloff (RoRo) Vessels, Scientific Core-Drilling, and Corporate and Other segments. The company provides refrigerated transportation of fruits and other perishable products; and reefer, car carrier and RoRo, and bulk goods. It also engages in the provision of lease financing to the industrial shipping industry across a diversified portfolio of shipping assets and counterparts, as well as funding to group companies. In addition, the company is involved in the production of potash for use in fertilizer production; bischofite for the construction industry; and magnesium chloride for de-icing and other related products. Further, it engages in the engineering, procurement, and construction of solar parks; and mines and markets various salt-based products, as well as offers abandoned caverns for waste storage. The company was incorporated in 1980 and is based in Luxembourg.
Full SEMUF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.